What does CUSIP 4525EP101 represent in this 13F holders report?

CUSIP 4525EP101 is the security identifier for IMUX - Immunic, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

How many institutions held IMUX - Immunic, Inc. - Common Stock, par value $0.0001 per share in Q1 2022?

78 institutional investors reported IMUX - Immunic, Inc. - Common Stock, par value $0.0001 per share for Q1 2022. Use the holders table for investor-level position and value details.

Immunic, Inc. - Common Stock, par value $0.0001 per share (IMUX)

CUSIP: 4525EP101

Q1 2022 13F Holders as of 31 Mar 2022

Security type / class: Equity / Common Stock, par value $0.0001 per share
Total 13F shares: 17,606,263
Total 13F value: $198,949,802
Share change: +3,899,142
Put/Call ratio: 51%
SEC-reported price per share: $11.30
Number of holders: 78
Value change: +$44,387,028
Number of buys: 34
Number of sells: 32
Shares outstanding: 14,280,377

Security key

4525EP101

Report period

Q1 2022

Institutions

Top holders

IMUX full security history Ownership snapshot Full 13F holder table IMMUNIC, INC. SEC filings IMMUNIC, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of IMUX - Immunic, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Omega Fund Management, LLC

Disclosed value leader

Omega Fund Management, LLC

Comparable rows

15/15

Latest evidence

31 Dec 2021

13F Lead comparable stake: 13% Showing 1-6 of 15 holder rows.

Quick read

Omega Fund Management, LLC leads the comparable SEC ownership view at 13%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Omega Fund Management, LLC's linked filing trail.

Comparable ownership Top 5

Omega Fund Management, LLC 13%

RTW INVESTMENTS, LP 12%

BlackRock Finance, Inc. 9.1%

Parkman Healthcare Partners LLC 6.8%

VANGUARD GROUP INC 6.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Omega Fund Management, LLC	13F Company 13F	13%	$17,113,000 1,788,160 shares	—	31 Dec 2021
RTW INVESTMENTS, LP	13F Company 13F	12%	$16,417,000 1,715,470 shares	—	31 Dec 2021
BlackRock Finance, Inc.	13F Company 13F	9.1%	$12,467,000 1,302,776 shares	—	31 Dec 2021
Parkman Healthcare Partners LLC	13F Company 13F	6.8%	$9,323,000 974,183 shares	—	31 Dec 2021
VANGUARD GROUP INC	13F Company 13F	6.3%	$8,630,000 901,830 shares	—	31 Dec 2021
Point72 Asset Management, L.P.	13F Company 13F	5.1%	$6,938,000 725,000 shares	—	31 Dec 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

17,606,263

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Holder diff

Investor	Q1 2022 Shares	Q1 2022 Shares	Share Diff	Share Chg %	Q1 2022 value	Q1 2022 value	Value change	Value Chg %